Genmab — Maj 2016
-
Som jeg tidligere har beskrevet så leder GILD efter en cutting edge teknologi, som om fem er er hot. Det ligner Genmabs knock off you socks antibodies. Men rigtigt,
at det er underligt at de ikke går efter et decideret senfase produkt - det er dog efter min mening fornuftigt nok, at de giver et bud på Genmab i +2000
-
+2000
-
ATH luk på 987.5
-
-
Bernstein positive på europæiske medicinalaktier http://npinvestor.dk/node/346373
-
Det lyder ikke usandsynligt .
-
God morgen. Husk spørgsmål til vores Q&A. i morgen kl. 17.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind